AMLODIPIN VALSARTAN HCT Mepha 10/160/25 100 pce

7680658900124 CH-65890 C09DX01 02.07.2.

Reimbursement limitations:

AMLOVALHCTME

Le traitement combiné d'AMLODIPIN-VALSARTAN-HCT-MEPHA et d'un antagoniste du calcium I.T. 02.06 et/ou d'un inhibiteur de …

AMLODIPIN VALSARTAN HCT Mepha 10/160/25 100 pce
AMLODIPIN VALSARTAN HCT Mepha 10/160/25 100 pce
AMLODIPIN VALSARTAN HCT Mepha 10/160/25 100 pce
1 / 3
google

Details

Product number
6589004
CPT
-
Packaging group
100
Unit
Tablette(n)
Composition
amlodipinum 10 mg ut amlodipini besilas, valsartanum 160 mg, hydrochlorothiazidum 25 mg, cellulosum microcristallinum, hydroxypropylcellulosum, silica colloidalis anhydrica, magnesii stearas, talcum, Überzug: poly(alcohol vinylicus), E 171, talcum, macrogolum 4000, acidi methacrylici copolymerum C, natrii hydrogenocarbonas corresp. natrium 0.005 mg, E 172 (flavum), E 172 (rubrum), pro compresso obducto.

Articles (1)

Amlodipin-Valsartan-HCT-Mepha 10mg/160mg/25mg, Filmtabletten
Filmtabletten
100
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
10/07/2023
Patient information leaflet
Français
10/07/2023
Patient information leaflet
Italien
10/07/2023
Professional SmPC
Allemand
10/07/2023
Professional SmPC
Français
10/07/2023

Detailed composition

Substance Quantity Type Category
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
160.0 MG Substance Wirkstoff (Principe actif)
(N/A)
25.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.005 MG Substance HBESI
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK

Reimbursement information

Public price
CHF 76.80
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/07/2020

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
65890
Drug name
Amlodipin-Valsartan-HCT-Mepha, Filmtabletten
Galenic form
FILM
ATC Code
C09DX01
Authorization status
Z
Dispensation category
B
First authorization
02/11/2016
Authorization expiration date
31/12/9999
IT number
02.07.2.
Domain
Human medicine
Field of application
Essentielle Hypertonie

Packaging details

Description (FR)
AMLODIPIN VALSARTAN HCT Mepha 10/160/25 100 pce
Description (DE)
AMLODIPIN VALSARTAN HCT Mepha 10/160/25 100 Stk
Market launch
02/11/2016
Narcotic (BTM)
No

Original drug

Exforge HCT, Filmtabletten
CHF 39.95
View original

Other packaging sizes

AMLODIPIN VALSARTAN HCT Mepha 5/160/12.5 28 pce
28 TABL
View
AMLODIPIN VALSARTAN HCT Mepha 5/160/12.5 98 pce
98 TABL
View
AMLODIPIN VALSARTAN HCT Mepha 5/160/12.5 100 pce
100 TABL
View
AMLODIPIN VALSARTAN HCT Mepha 5/160/25 28 pce
28 TABL
View
AMLODIPIN VALSARTAN HCT Mepha 5/160/25 98 pce
98 TABL
View
AMLODIPIN VALSARTAN HCT Mepha 5/160/25 100 pce
100 TABL
View
AMLODIPIN VALSARTAN HCT Mepha 10/160/12.5 28 pce
28 TABL
View
AMLODIPIN VALSARTAN HCT Mepha 10/160/12.5 98 pce
98 TABL
View
AMLODIPIN VALSARTAN HCT Mepha 10/160/12.5 100 pce
100 TABL
View
AMLODIPIN VALSARTAN HCT Mepha 10/160/25 28 pce
28 TABL
View